Thus, it will invest RON4.5 million in the acquisition of pharmacy licenses, RON1.62 million in vehicles, RON1.57 million in revamping buildings and RON838,500 in equipment and IT licenses.
Ropharma has two production units, in Targu Mures and Chisinau, where it makes nutritional supplements and medicines. The distribution company also has five warehouses, an own drugstore network of 132 units and a private hospital in Brasov city.
Ropharma also targets partnerships with foreign companies, thus, it held talks with partners from Italy, Ukraine, Latvia, Asia and the Middle East, the company said in a statement. The company’s product portfolio includes 68 products.
Ropharma Brasov reported sales worth RON418.2 million (EUR94.2 million) in 2014, up 2% from RON411.2 million a year earlier, while its net profit rose 12% to RON8.04 million, compared with RON7.2 million in 2013
Ropharma estimated a 5% sales increase for 2014, at RON430 million, and a 25% higher profit, at RON9 million.
Businessman Mihai Miron indirectly owns 31.78% of Ropharma. He controls 14.12% via Rimia Investments and 17.66% via ADD Pharmaceuticals, both registered in Cyprus.